Events and Presentations

DAY HI:
DAY LOW:
VOLUME:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events and Presentations

Presentations and Posters
Date Title Format
Oct 07, 2021
AACR-NCI-EORTC – Virtual International Conference: Pan-ErbB inhibition enhances activity of KRASG12C inhibitors in preclinical models of KRASG12C mutant cancers
Sep 18, 2021
ESMO Congress 2021: Efficacy and Safety of Poziotinib in Treatment-naïve NSCLC Harboring HER2 exon 20 Mutations: A Multinational Phase 2 Study (ZENITH20-4)
Sep 09, 2021
Current Corporate Presentation
Jun 04, 2021
2021 ASCO Annual Meeting: CNS activity of poziotinib in NSCLC with exon 20 insertion mutations
Apr 10, 2021
Poziotinib administered twice daily improves safety and tolerability in patients with EGFR or HER2 exon 20 mutations
Mar 05, 2021
38th Annual Miami Breast Cancer Conference: Interim safety evaluation of same-day dosing of eflapegrastim in patients with early-stage breast cancer (ESBC) receiving docetaxel and cyclophosphamide (TC)
Mar 02, 2021
ESMO TAT Virtual Congress 2021: Safety, tolerability and preliminary efficacy of poziotinib with twice daily strategy in EGFR/HER2 Exon 20 mutant non-small cell lung cancer